Stay updated on Pembrolizumab + Radiation in SCCHN Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Radiation in SCCHN Clinical Trial page.

Latest updates to the Pembrolizumab + Radiation in SCCHN Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision metadata updated to add v3.4.2 and remove v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision indicator updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedAdded Show glossary option and new metadata labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check42 days agoChange Detected- Revision: v3.3.4 added and Revision: v3.3.3 removed are administrative/versioning updates and do not modify study content. - There is no impact on the study details, eligibility criteria, outcomes, or other core information. - To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedLocations section updated; Maryland, North Carolina, and Pennsylvania sites added and the HHS Vulnerability Disclosure link removed as part of revision 3.3.3.SummaryDifference0.4%

- Check91 days agoChange DetectedThe Publications section now states that entries are automatically filled from PubMed and may not all pertain to the study. The revision version has been updated to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab + Radiation in SCCHN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Radiation in SCCHN Clinical Trial page.